Blood Cancer

Individuals prescribed the antidiabetes treatment metformin less likely developed a myeloproliferative neoplasm —potentially also reducing a person’s chances for developing certain cancers — according to data published in Blood Advances.

The FDA placed a clinical hold on studies evaluating magrolimab for the treatment of acute myeloid leukemia and myelodysplastic syndromes, according to a statement released by the manufacturer.

PHILADELPHIA — In this Healio video exclusive, Michael C. Honigberg, MD, MPP, discusses the latest research on clonal hematopoiesis of indeterminate potential in blood cells, an emerging risk factor for CVD.

Obesity appeared strongly associated with clonal hematopoiesis of indeterminate potential — a blood condition linked to increased risk for blood cancer, according to study results published in The Journal of Clinical Investigation.

Researchers at Tisch Cancer Center have created innovative models of acute myeloid leukemia, offering an unprecedented resource for studying this deadly blood cancer, according to a study published in Blood Cancer Discovery.

Patients with hematologic malignancies and penicillin or amoxicillin allergies passed challenges to these labels and received beta-lactam antibiotics, according to a study published in Antimicrobial Stewardship & Healthcare Epidemiology.

The COVID-19 pandemic has exacerbated an already ongoing staffing crisis in oncology, as well as throughout the entire health care workforce, experts said.

Only a decade ago, many in oncology considered chimeric antigen receptor T-cell therapy too fringe for real-world use.

Gerontology researchers and hematologic oncology investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute have devised a scale for assessing high-risk medications in older patients with blood cancers.

The FDA issued a warning about a potentially increased risk for death or serious adverse effects with duvelisib, an approved blood cancer therapy.